Stimulator of interferon genes-associated vasculopathy with onset in infancy: A mimic of childhood granulomatosis with polyangiitis

JAMA Dermatology

Volumn 151, Issue 8, 2015, Pages 872-877

  Munoz, Justine ^a,b   Rodière, Michel ^b,c   Jeremiah, Nadia ^d,e,f   Rieux Laucat, Frédéric ^d,e,f   Oojageer, Anthony ^g   Rice, Gillian I ^g   Rozenberg, Flore ^e,h   Crow, Yanick J ^d,e,f,g   Bessis, Didier ^a,b,f  

^a HÔPITAL SAINT ELOI   (France)

^b UNIV MONTPELLIER   (France)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f INSERM   (France)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

^h INSERM U1058 ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; COLCHICINE; CORTICOSTEROID; HUMAN GROWTH HORMONE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; NEUTROPHIL CYTOPLASMIC ANTIBODY; NIFEDIPINE; PREDNISOLONE; INTERFERON; MEMBRANE PROTEIN; MPYS PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; CASE REPORT; CHILDHOOD DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; DRUG EFFICACY; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; FEVER; FINGER AMPUTATION; GENE; GENETIC ANALYSIS; GENETIC DISORDER; GESTATIONAL AGE; GROWTH DISORDER; HEAD CIRCUMFERENCE; HISTOLOGY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INFLAMMATORY INFILTRATE; INTERSTITIAL LUNG DISEASE; INTRAUTERINE GROWTH RETARDATION; KERATINOCYTE; LABORATORY TEST; LUNG LAVAGE; MALE; NEWBORN; NOSE SEPTUM PERFORATION; ONSET AGE; PRIORITY JOURNAL; RECURRENT DISEASE; SEASONAL VARIATION; SKIN DEFECT; SKIN INFILTRATE; SKIN MANIFESTATION; SKIN NECROSIS; SOMATIC MUTATION; STIMULATOR OF INTERFERON GENES ASSOCIATED VASCULOPATHY WITH ONSET IN INFANCY; TACHYPNEA; TELANGIECTASIA; TMEM173 GENE; VASCULAR DISEASE; WEGENER GRANULOMATOSIS; WINTER; GENETICS; GRANULOMATOSIS WITH POLYANGIITIS; INFANT; MUTATION; PATHOLOGY; PHENOTYPE; SKIN DISEASES, VASCULAR; UPREGULATION;

GRANULOMATOSIS WITH POLYANGIITIS; HUMANS; INFANT; INTERFERON TYPE I; MALE; MEMBRANE PROTEINS; MUTATION; PHENOTYPE; SKIN DISEASES, VASCULAR; UP-REGULATION;

EID: 84941702440     PISSN: 21686068     EISSN: 21686084     Source Type: Journal    
DOI: 10.1001/jamadermatol.2015.0251     Document Type: Article

References (15)

1. Crow YJ. Type I interferonopathies: a novel set of inborn errors of immunity. Ann N Y Acad Sci. 2011; 1238:91-98.
2. Liu Y, Jesus AA, Marrero B, et al. Activated STING in a vascular and pulmonary syndrome. N Engl JMed. 2014;371(6):507-518.
3. Crow YJ, Casanova JL. STING-associated vasculopathy with onset in infancy-a new interferonopathy. N Engl J Med. 2014;371(6):568-571.
4. Carrington CB, Liebow A. Limited forms of angiitis and granulomatosis of Wegener's type. Am J Med. 1966;41(4):497-527.
5. Sinovich V, Snow J. Protracted superficial Wegener's granulomatosis. Australas J Dermatol. 2003;44(3):207-214.
6. Gajic-Veljic M, Nikolic M, Peco-Antic A, Bogdanovic R, Andrejevic S, Bonaci-Nikolic B. Granulomatosis with polyangiitis (Wegener's granulomatosis) in children: report of three cases with cutaneous manifestations and literature review. Pediatr Dermatol. 2013;30(4):e37-e42.
7. Rice G, Newman WG, Dean J, et al. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am J Hum Genet. 2007;80(4):811-815.
8. Rice GI, Bond J, Asipu A, et al. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet. 2009;41(7):829-832.
9. Briggs TA, Rice GI, Daly S, et al. Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat Genet. 2011;43(2):127-131.
10. Liu Y, Ramot Y, Torrelo A, et al. Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum. 2012; 64(3):895-907.
11. Kunimoto K, Kimura A, Uede K, et al. A new infant case of Nakajo-Nishimura syndrome with a genetic mutation in the immunoproteasome subunit: an overlapping entity with JMP and CANDLE syndrome related to PSMB8 mutations. Dermatology. 2013;227(1):26-30.
12. Bachmeyer C, Farge D, Gluckman E, Miclea JM, Aractingi S. Raynaud's phenomenon and digital necrosis induced by interferon-alpha. Br J Dermatol. 1996;135(3):481-483.
13. Bugatti L, Filosa G, Nicolini M, Filosa A, Verdolini R. Atrophie blanche associated with interferon-alfa adjuvant therapy for melanoma: a cutaneous side effect related to the procoagulant activity of interferon? Dermatology. 2002;204(2):154.
14. Bessis D, Charron A, Rouzier-Panis R, Blatière V, Guilhou JJ, Reynes J. Necrotizing cutaneous lesions complicating treatment with pegylated-interferon alfa in an HIV-infected patient. Eur J Dermatol. 2002;12(1):99-102.
15. Slavenburg S, Heijdra YF, Drenth JP. Pneumonitis as a consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: a review of the literature. Dig Dis Sci. 2010;55(3):579-585.